The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Monitoring ctDNA in r/r DLBCL patients following the CAR T-cell therapy axicabtagene ciloleucel: Day 28 landmark analysis.
 
Matthew Joshua Frank
Employment - Roche (I)
Stock and Other Ownership Interests - Roche (I)
 
Nasheed M. Hossain
No Relationships to Disclose
 
Ali Abbas Bukhari
No Relationships to Disclose
 
Erin Dean
No Relationships to Disclose
 
Jay Y. Spiegel
No Relationships to Disclose
 
Gursharan K. Claire
No Relationships to Disclose
 
Ilan Kirsch
Employment - Adaptive Biotechnologies
 
Allison Jacob
Employment - Adaptive Biotechnologies
Stock and Other Ownership Interests - Adaptive Biotechnologies
 
Chelsea D. Mullins
Employment - Adaptive Biotechnologies
Stock and Other Ownership Interests - Adaptive Biotechnologies
 
Lik Wee Lee
Employment - Adaptive Biotechnologies
 
Katherine A. Kong
No Relationships to Disclose
 
Juliana K. Craig
No Relationships to Disclose
 
Crystal Mackall
Stock and Other Ownership Interests - Apricity Health; Lyell Immunopharma; PACT Pharma; Unum Therapeutics; Vor Biopharma
Consulting or Advisory Role - Adaptimmune; Apricity Health; GlaxoSmithKline; Nektar; PACT Pharma; Roche; Unum Therapeutics; Vor Biopharma
Research Funding - Bluebird Bio; Obsidian Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Travel, Accommodations, Expenses - Adaptimmune; Apricity Health; GlaxoSmithKline; Lyell Immunopharma; Nektar; Roche; Unum Therapeutics
 
Aaron Rapoport
No Relationships to Disclose
 
Saurabh Dahiya
Consulting or Advisory Role - Kite, a Gilead company
 
Frederick Lundry Locke
Consulting or Advisory Role - Cellular Biomedicine Group; Kite, a Gilead company
 
David Bernard Miklos
Honoraria - Sanofi; Sanofi
Consulting or Advisory Role - Adaptive Biotechnologies; Janssen; Janssen; Janssen; Juno/Celgene; Kite, a Gilead company; Novartis; Pharmacyclics
Research Funding - Adaptive Biotechnologies; Adaptive Biotechnologies; Kite, a Gilead company; Novartis; Pharmacyclics; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Juno Therapeutics; Kite, a Gilead company; Pharmacyclics/Janssen; Sanofi